| News |
| 31 January 2012 - by |
|
The development of world's first artificial testicle for production of human sperm has been given the go ahead...[Read More] |
 |
| 31 January 2012 - by |
|
Two breast cancer drugs, Avastin and Sutent, may inadvertently aid cancer growth, a study in mice suggests. The drugs, designed to reduce the blood supply to tumours, were found to encourage cancer stem cell growth, potentially fuelling the spread of the cancer...[Read More] |
| |
| 31 January 2012 - by |
|
A new method of looking for chromosomal abnormalities in embryos can increase the chance of successful IVF implantation, a recent study in the journal Fertilisation In Vitro has shown....[Read More] |
| |
|
Early life factors may impact genes of Glasgow's poorest, study claims |
| 31 January 2012 - by |
|
Unhealthy lifestyles associated with social deprivation may have detrimental effects on DNA before birth, say scientists. A study of adults living in Glasgow shows a correlation between deprivation and DNA methylation - a normal process that occurs mainly during embryonic development and regulates gene activity...[Read More] |
| |
| 31 January 2012 - by |
|
Thirteen genomic regions appear to influence the age at onset of menopause, according to a genetic study. These regions contain genes involved in DNA repair and immune responses, processes not previously linked to menopause...[Read More] |
| |
| 31 January 2012 - by |
|
Genomic medicine will be at the forefront of the NHS, according to a report released last week by the Human Genomics Strategy Group (HGSG). The report highlights the UK's achievements in genomic technology to date and makes six recommendations to ensure future benefit of genomic innovation within the NHS...[Read More] |
| |
|
Roche attempts $5.7bn takeover of DNA sequencing firm Illumina |
| 31 January 2012 - by |
|
Swiss pharmaceutical company Roche has made an unsolicited bid worth $5.7 billion to takeover US DNA sequencing firm Illumina....[Read More] |
| |
| 31 January 2012 - by |
|
A clinical trial testing the safety of using human embryonic stem cell (hESC) in the treatment of progressive eye conditions has been carried out by researchers in the USA...[Read More] |
| |
| 23 January 2012 - by |
|
An experimental genetic technique to prevent serious diseases from passing between mother and child is to receive £5.8 million funding. The Wellcome Trust is contributing £4.4 million to the new Centre for Mitochondrial Research at Newcastle University...[Read More] |
| |
| 23 January 2012 - by |
|
The gene causing a skin disorder which predisposes to oesophageal cancer has been identified. More than nine out of ten people with tylosis, which causes thickening of the skin on the palms and soles, will develop oesophageal cancer before the age of 65, but until now the reason for this was obscure...[Read More] |
| |
| 23 January 2012 - by |
|
Researchers from Scotland have found around one-quarter of changes in intelligence observed from childhood to old age may be due to our genes. Although the researchers accept the finding is not statistically significant, it is the first to estimate the contribution of genetic variations to cognitive ageing....[Read More] |
| |
|
Myriad Genetics acquires patent on another breast cancer-linked gene |
| 23 January 2012 - by |
|
Myriad Genetics, a leading US molecular diagnostic company, has been granted exclusive rights to an analysis of the RAD51C gene. Mutations of the gene have been associated with an increased risk for hereditary breast and ovarian cancer and the company now hopes to develop a commercial test for RAD51C....[Read More] |
| |
| 23 January 2012 - by |
|
A test has been developed to determine the sex of a fetus from only five weeks old. The test relies on a blood sample from the mother and therefore carries no risk to the child...[Read More] |
| |
| 23 January 2012 - by |
|
Mutations in a single gene could be used to identify breast cancer tumours that can be tackled with cholesterol-lowering statins, a recent study has found. Scientists identified a link between a cholesterol-building mechanism in the body and disorganised cell growth indicative of cancer...[Read More] |
| |
| 23 January 2012 - by |
|
Two independent studies have suggested new targets for treating neurodegenerative diseases...[Read More] |
| |
| 16 January 2012 - by |
|
A US biotechnology firm has unveiled an automated desktop DNA sequencer that can decode the sequence of the human genome in one day for as little as $1000 (£650). Given its first public viewing at a consumer electronics show in Las Vegas, Life Technologies Corporation's Ion Proton sequencer uses microchips similar to those found in digital cameras...[Read More] |
| |
| 16 January 2012 - by |
|
A rare gene variant that could increase the risk of prostate cancer has been identified by researchers in the USA. Although the variant accounts for only a small fraction of all prostate cancers, the study found it was more common in men with an inherited form of the cancer and in those who are diagnosed before the age of 55...[Read More] |
| |
| 16 January 2012 - by |
|
The number of publicly funded IVF cycles dropped by nearly 14 percent this financial year in the UK, an investigation by the GP magazine Pulse has revealed...[Read More] |
| |
| 16 January 2012 - by |
|
Analysis of person's DNA when they are still young could provide important clues about how long they will live, if a study on zebra finches is anything to go by. Research shows that the best indicator of the birds' longevity is the length of a section of genetic code at the end of their chromosomes, called the telomere...[Read More] |
| |
|
Mice live up to three times longer after progenitor cell injections |
| 16 January 2012 - by |
|
Stem cell injections have been found to slow down the effects of aging in mice. Researchers have developed a stem cell treatment that significantly slows down aging and increases life span in mice with progeria, a rare genetic disease causing advanced aging...[Read More] |
| |
| Progress Educational Trust, 140 Grays Inn Road, London WC1X 8AX, UK Tel: +44 (0)20 7278 7870 Email: Limited company registered in England and Wales no 07405980 Charity registered in England and Wales no 1139856 | Website developed and built by Face to Face |
© 1999, 2012
BioNews